Variables | Intervention Group, n = 35 | Control Group, n = 35 | p Intergroup** | ||||||
---|---|---|---|---|---|---|---|---|---|
T0 | T6 | T12 | T24 | T0 | T6 | T12 | T24 | ||
BASDAI | 3.46 (2.39) | 2.85 (2.20)* | 2.75 (2.12)* | 2.87 (1.97) | 3.62 (2.06) | 3.10 (2.00)* | 2.79 (1.99)* | 3.27 (2.07) | 0.645 |
ASDAS, CRP | 2.44 (1.07) | 2.00 (0.95)* | 1.98 (0.93)* | 2.10 (0.92) | 2.24 (0.91) | 2.13 (0.88)* | 2.00 (0.94)* | 2.24 (0.89) | 0.928 |
ASDAS, ESR | 2.35 (0.93) | 2.09 (0.89)* | 2.05 (0.92)* | 2.24 (0.95) | 2.31 (0.83) | 2.18 (0.82)* | 2.00 (0.87)* | 2.24 (0.84) | 0.991 |
CRP, mg/l | 10.49 (11.90) | 7.04 (7.64) | 7.14 (8.21) | 6.53 (6.01) | 6.01 (7.33) | 5.50 (6.19) | 4.95 (4.86) | 7.84 (11.59) | 0.290 |
ESR, mm/h | 18.5 (12.5) | 17.0 (10.0) | 17.5 (12.8) | 20.5 (15.2) | 17.1 (13.6) | 16.23 (13.7) | 14.1 (12.5) | 14.7 (9.7) | 0.264 |
↵* p < 0.05 compared to T0.
↵** ANOVA test.
AS: ankylosing spondylitis; T0: baseline assessment before randomization; T6: assessment 6 weeks after the start of the program; T12: assessment 12 weeks after the start of the program; T24: assessment 24 weeks after the start of the program; BASDAI: Bath AS Disease Activity Index; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; ASDAS: AS Disease Activity Score.